[The efficacy of Neovir in the combined treatment of patients with operable tumors of the gastrointestinal tract].
Under observation there were 32 patients with operable tumors of the gastro-intestinal tract. The average age of the patients was (64.8 +/- 7.5) years. Patients of the control group (18 patients were given the routine complex treatment. The main group (14 patients) were additionally given the interferonogenic immunomodulator "Neovir" which resulted in lower risk of the appearance of pyo-septic complications. It was confirmed by positive dynamics of the indices of cellular immunity, intensified production of proinflammatory cytokines and interferon-alpha.
Glushkov
N I
NI
Shabashova
N V
NV
Frolova
E V
EV
Uchevatkina
A E
AE
Kubachev
K G
KG
Novakovskiĭ
V V
VV
Popkov
V V
VV
D000166:Acridines / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000917:Antibody Formation / Q000187:drug effects; D017024:Chemotherapy, Adjuvant; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007369:Interferon Inducers / Q000627:therapeutic use*; D008875:Middle Aged; D011182:Postoperative Care; D011300:Preoperative Care; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000166:Acridines; D000276:Adjuvants, Immunologic; D007369:Interferon Inducers; C077681:Camedon
Effektivnost' Neovira v kompleksnom lechenii bol'nykh s operabel'nymi opukholiami zheludochno-kishechnogo trakta.